In tumor models, increased cell proliferation and tumor development have been closely associated with FGF19 overexpression; for example, in HCC models, significant upregulation of proliferation markers such as Ki-67 by FGF19 has been demonstrated 127. This evidence concerns the gene FGF19 and hepatocellular carcinoma.